Placental Expression of NEMO Protein in Normal Pregnancy and Preeclampsia.

Dis Markers 2019 2;2019:8418379. Epub 2019 Jan 2.

Department of Medical Biotechnology, Medical University of Lodz, Zeligowskiego 7/9, Lodz, Poland.

Background: Preeclamptic pregnancies often present an intensified inflammatory state associated with the nuclear activity of NFB. NEMO is an essential regulator of nuclear factor kappa B (NFB) in cytoplasmic and nuclear cellular compartments. The aim of the present study is to examine the level and localization of the NEMO protein in preeclamptic and nonpreeclamptic placentas.

Methods: The study includes 97 preeclamptic cases and 88 controls. NEMO distribution was analyzed immunohistochemically. Its localization in the nuclear and cytoplasmic fractions, as well as in total homogenates of placental samples, was studied by western blot and ELISA.

Results: The western blot and ELISA results indicate a significant difference in NEMO concentration in the total and nuclear fractions between preeclamptic and control samples ( < 0.01 and < 0.001, respectively). In the cytoplasmic complement, similar levels of NEMO were found in preeclamptic and control placentas. In addition, immunohistochemical staining revealed that the NEMO protein is mainly localized in the syncytiotrophoblast layer, with controls demonstrating a stronger reaction with NEMO antibodies. This study also shows that the placental level of NEMO depends on the sex of the fetus.

Conclusions: The depletion of the NEMO protein in the cellular compartments of placental samples may activate one of the molecular pathways influencing the development of preeclampsia, especially in pregnancies with a female fetus. A reduction of the NEMO protein in the nuclear fraction of preeclamptic placentas may intensify the inflammatory state characteristic for preeclampsia and increase the level of apoptosis and necrosis within preeclamptic placentas.

Download full-text PDF

Source
https://www.hindawi.com/journals/dm/2019/8418379/
Publisher Site
http://dx.doi.org/10.1155/2019/8418379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339720PMC
May 2019

Publication Analysis

Top Keywords

nemo protein
20
nemo
11
preeclamptic control
8
western blot
8
inflammatory state
8
placental samples
8
preeclamptic placentas
8
cellular compartments
8
preeclamptic
7
nuclear
6
protein
5
cytoplasmic complement
4
complement levels
4
levels nemo
4
0001 cytoplasmic
4
001 0001
4
layer controls
4
nemo preeclamptic
4
syncytiotrophoblast layer
4
placentas addition
4

Similar Publications

Finding NEMO in preeclampsia.

Am J Obstet Gynecol 2016 Apr 10;214(4):538.e1-538.e7. Epub 2015 Nov 10.

Department of Obstetrics and Gynecology, Polish Mother's Memorial Hospital-Research Institute in Lodz, Poland.

Background: The mechanism of preeclampsia and its way of inheritance are still a mystery. Biochemical and immunochemical studies reveal a substantial increase in tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 concentrations in the blood of women with preeclampsia. The level of these factors is regulated by nuclear facxtor-kappa B, whose activation in a classical pathway requires inhibitory kappa B kinase gamma (known as NEMO or IKBKG). Read More

View Article and Full-Text PDF
April 2016

Double hit of NEMO gene in preeclampsia.

PLoS One 2017 27;12(6):e0180065. Epub 2017 Jun 27.

Department of Obstetrics and Gynecology, Polish Mother's Memorial Hospital-Research Institute in Lodz, Lodz, Poland.

The precise etiology of preeclampsia is unknown. Family studies indicate that both genetic and environmental factors influence its development. One of these factors is NFkB, whose activation depends on NEMO (NFkB essential modulator. Read More

View Article and Full-Text PDF
September 2017

[Expression and significance of SATB1 and wnt/β-catenin signaling molecule in the placenta of preeclampsia].

Zhonghua Fu Chan Ke Za Zhi 2015 Apr;50(4):283-90

Department of Obstetrics and Gynecology, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; Email:

Objective: To explore the role of specific AT rich sequence binding protein 1(SATB1) and wnt/β-catenin signaling pathways in the regulation of trophoblast invasion and its effect in the pathogenesis of preeclampsia.

Methods: From March 2013 to March 2014, 20 cases of human villous tissues (early pregnancy group) from women of 8-10 gestational weeks who received artificial abortion at the First Affiliated Hospital of Chongqing Medical University, 18 cases of placental tissues (mid-pregnancy group) from women of 18-20 gestational weeks who had labor induction by water bag, 20 cases of placental tissues (normal full-term group) from healthy full-term pregnancy women and 20 cases of placental tissues (preeclamptic group) from women with preeclampsia who received elective c-section in were collected. Immunohistochemical SP method was utilized to determine the position of SATB1 and beta-catenin in villous tissues or placental tissues. Read More

View Article and Full-Text PDF
April 2015

Canonical, Non-Canonical and Atypical Pathways of Nuclear Factor кb Activation in Preeclampsia.

Int J Mol Sci 2020 Aug 4;21(15). Epub 2020 Aug 4.

Department of Obstetrics and Gynecology, Polish Mother's Memorial Hospital-Research Institute, 93-338 Lodz, Poland.

Although higher nuclear factor κB (NFκB) expression and activity is observed in preeclamptic placentas, its mechanism of activation is unknown. This is the first study to investigate whether the canonical, non-canonical, or atypical NFκB activation pathways may be responsible for the higher activation of NFκB observed in preeclamptic placentas. The study included 268 cases (130 preeclamptic women and 138 controls). Read More

View Article and Full-Text PDF
August 2020